Table 2 Characteristics of patients eligible for this study
Characteristics | Pre-interventional Period (n = 187, %) | Interventional Period (n = 679, %) | Total (n = 866, %) | P |
|---|---|---|---|---|
Female Sex | 93 (49.7%) | 315 (46.4%) | 408 (47.1%) | 0.42 |
Age, median years (IQR) | 66 (55, 78) | 64 (54, 77) | 65 (54, 77) | 0.46 |
History of hospitalization within 90 days | 57 (30.5%) | 209 (30.8%) | 266 (30.7%) | 0.94 |
History of CRAB positive within 90 days | 5 (2.7%) | 11 (1.6%) | 16 (1.8%) | 0.34 |
Duration of ICU stay, median days (IQR) | 5 (3.5, 9) | 6 (4, 10) | 6 (4, 10) | 0.124 |
Intubation | 132 (70.6%) | 460 (67.8%) | 592 (68.4%) | 0.48 |
Circulatory disease | 38 (20.3%) | 115 (16.9%) | 153 (17.7%) | 0.28 |
Chronic kidney disease | 34 (18.2%) | 123 (18.1%) | 157 (18.1%) | 0.98 |
Gastrointestinal disease | 5 (2.7%) | 43 (6.3%) | 48 (5.5%) | 0.053 |
Chronic respiratory disease | 28 (15.0%) | 87 (12.8%) | 115 (13.3%) | 0.44 |
Hepatobiliary disease | 10 (5.3%) | 26 (3.8%) | 36 (4.2%) | 0.36 |
Cerebral vascular disease | 8 (4.3%) | 55 (8.1%) | 63 (7.3%) | 0.075 |
Malignancy (hematologic malignancies and solid tumor) | 41 (21.9%) | 188 (27.7%) | 229 (26.4%) | 0.114 |
Hypertension | 85 (45.5%) | 225 (33.1%) | 310 (35.8%) | 0.002 |
Diabetes mellitus | 62 (33.2%) | 160 (23.6%) | 222 (25.6%) | 0.008 |
Autoimmune diseases | 9 (4.8%) | 28 (4.1%) | 37 (4.3%) | 0.68 |
Infectious diseases | 62 (33.2%) | 167 (24.6%) | 229 (26.4%) | 0.019 |